Category: 8. Health

  • Elbows Up and Eyes Wide Open

    Elbows Up and Eyes Wide Open

    PSYCHIATRIC VIEWS ON THE DAILY NEWS

    If you have been following my recent columns, you will know that my wife and I have been in Canada, focusing as we do annually on the Stratford Shakespeare Festival. The plays that we saw seemed terribly prophetic, chosen well before the emergence of our current presidential administration and reduction of psychiatric services. Multiple social psychiatric issues became readily apparent in the plays and elsewhere, seeming to require multiple columns to discuss them. This one is slated to be our last in the series.

    Due to the threats from the United States for Canada to become our 51st state and the initiation of higher tariffs, we had concerns about how we would be welcomed. We debated even coming, but that concern turned out to be an erroneous fantasy. We could not have been more welcomed, and then immediately helped when we had car trouble twice. I just put up our hood, and like magic, Canadians came to our aid.

    We also found out how the threats to their political independence was rallying Canadian citizens towards greater unity and a Canadian identity of working multiculturalism. Whether Canada should become capable of nuclear weapons has even emerged. As applicable to other belief systems and countries, external threats often increase internal unity.

    One of the Canadian responses was the rallying cry “elbows up.” I had a vague memory that it related to their love of hockey. Elbows up referred to a way to both protect oneself and also be aggressive at times, both defensive and offensive. Hence, the phrase now reflects Canada’s political response to being threatened and absorbed by the United Stares.

    It also seemed to me that the rallying cry could reflect our internal political conflict in the United States and the potential response of psychiatry. We both need to defend against the reduction of federal support of our institutions’ services, as well as to be more proactive in creating alternatives. Once again, the Canadian single payer system and lack of business control has produced a system of greater and enviable clinical satisfaction.

    Come to think of it, we do the same in clinical practice when the outcomes of clinical care are threatened in any way. We are ethically required to fight back and find alternatives, even as we experience burnout at epidemic rates.

    Sometimes, elbows up is done with eyes closed in fear. That can lead to even more risk. So I would add approaching our current politically-based present psychiatric challenges with eyes wide open in order to best recognize our obstacles and dangers.

    Dr Moffic is an award-winning psychiatrist who specialized in the cultural and ethical aspects of psychiatry and is now in retirement and retirement as a private pro bono community psychiatrist. A prolific writer and speaker, he has done a weekday column titled “Psychiatric Views on the Daily News” and a weekly video, “Psychiatry & Society,” since the COVID-19 pandemic emerged. He was chosen to receive the 2024 Abraham Halpern Humanitarian Award from the American Association for Social Psychiatry. Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. He presented the third Rabbi Jeffrey B. Stiffman lecture at Congregation Shaare Emeth in St. Louis on Sunday, May 19, 2024. He is an advocate and activist for mental health issues related to climate instability, physician burnout, and xenophobia. He is now editing the final book in a 4-volume series on religions and psychiatry for Springer: Islamophobia, anti-Semitism, Christianity, and now The Eastern Religions, and Spirituality. He serves on the Editorial Board of Psychiatric Times.

    Continue Reading

  • Scientists detect virus traces in blood that may unlock long COVID’s mystery

    Scientists detect virus traces in blood that may unlock long COVID’s mystery

    Researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, and the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center have identified a potential biomarker for long COVID.

    If the findings of their study are confirmed by other research centers, the biomarker could be the first specific and quantifiable indicator for confirming long COVID. Currently, clinicians confer a diagnosis of long COVID based upon a collection of symptoms that patients develop after SARS-CoV-2 infection.

    “If a patient arrives in clinic and they relate the persistence of typical signs and symptoms of long COVID, 12 weeks or more after COVID -19 infection, I give them a presumptive diagnosis, but I don’t have any blood tests or biomarkers to confirm this diagnosis,” said William Stringer, M.D., a Lundquist Institute investigator and senior author on the study.

    The study results, reported in the journal Infection, detail the detection of SARS-CoV-2 protein fragments within extracellular vesicles (EVs) — tiny, naturally occurring packages that help cells share proteins, metabolites, and other materials. The researchers collected and analyzed blood samples from 14 patients over 12 weeks of aerobic exercise training (56 samples in all) in a clinical trial led by Stringer in long COVID.

    The researchers found 65 distinct protein fragments from SARS-CoV-2 inside the EVs. These fragments come from the virus’s Pp1ab protein, an RNA Replicase enzyme which is key to how the virus copies itself and makes other viral particles. This protein is found uniquely in SARS-CoV-2, and not in uninfected human cells, noted Asghar Abbasi, Ph.D., a Lundquist Institute investigator and first author of the study.

    Significantly, the researchers found that these viral peptides were demonstrated in each subject, but not each blood draw, in the EVs of Long COVID patients and were not detected in a separate control group of pre-pandemic EV samples.

    These findings add to growing evidence that suggests that SARS-CoV-2 may persist in certain body tissues long after the initial infection. Some groups hypothesize these lingering viral reservoirs could play a role in Long COVID. How the virus reaches tissues without its usual entry points — such as the brain — remains an open question, and may be related to EV particles.

    “We thought that maybe if the virus is circulating or moving in the body, we should try to see if EVs are carrying those viral fragments,” Abbasi explained.

    This idea became part of an ongoing clinical trial led by Drs. Abbasi and Stringer, which was already studying EVs to see if they are linked to changes in immune function related to exercise and post-exertional malaise, a common symptom in these patients.

    “While promising, the molecular signal of the viral peptides within the study samples was observed to be subtle and not consistently detected at every blood collection time point,” said Patrick Pirrotte, Ph.D., associate professor at TGen, director of the Integrated Mass Spectrometry Shared Resource at TGen and City of Hope, and co-senior author of the study. “There’s still a lot to unpack that we don’t know at this point.”

    For instance, he added, the researchers don’t know if the exercise itself drives the expression of viral programs intracellularly, and then those viral programs result in proteins that are going to be shed, or if there is a permanent reservoir in those cells, and it’s just a matter of detecting it at a certain time point. Although the identified peptides originated from one of the virus’ largest proteins, the researchers did not detect other comparably large proteins indicative of active viral replication. It’s possible that the peptides contained in the EVs are just molecular “trash” leftover after the formation of new viral proteins.

    “We haven’t run [our tests] on people without long COVID symptoms who are currently, or who were, infected with COVID,” said Stringer. “This raises the question: is this just continuing to take out the trash from the COVID infected cell or is this really ongoing replication someplace? I think that’s the mechanistic issue that needs to be resolved in future studies.”

    The Pulmonary Education and Research Foundation (PERF) and the UCLA David Geffen School of Medicine (DGSoM)-Ventura County Community Foundation (VCCF) funded this research.

    Continue Reading

  • Man develops rare condition after ChatGPT query over stopping eating salt | ChatGPT

    Man develops rare condition after ChatGPT query over stopping eating salt | ChatGPT

    A US medical journal has warned against using ChatGPT for health information after a man developed a rare condition following an interaction with the chatbot about removing table salt from his diet.

    An article in the Annals of Internal Medicine reported a case in which a 60-year-old man developed bromism, also known as bromide toxicity, after consulting ChatGPT.

    The article described bromism as a “well-recognised” syndrome in the early 20th century that was thought to have contributed to almost one in 10 psychiatric admissions at the time.

    The patient told doctors that after reading about the negative effects of sodium chloride, or table salt, he consulted ChatGPT about eliminating chloride from his diet and started taking sodium bromide over a three-month period. This was despite reading that “chloride can be swapped with bromide, though likely for other purposes, such as cleaning”. Sodium bromide was used as a sedative in the early 20th century.

    The article’s authors, from the University of Washington in Seattle, said the case highlighted “how the use of artificial intelligence can potentially contribute to the development of preventable adverse health outcomes”.

    They added that because they could not access the patient’s ChatGPT conversation log, it was not possible to determine the advice the man had received.

    Nonetheless, when the authors consulted ChatGPT themselves about what chloride could be replaced with, the response also included bromide, did not provide a specific health warning and did not ask why the authors were seeking such information – “as we presume a medical professional would do”, they wrote.

    The authors warned that ChatGPT and other AI apps could ‘“generate scientific inaccuracies, lack the ability to critically discuss results, and ultimately fuel the spread of misinformation”.

    ChatGPT’s developer, OpenAI, has been approached for comment.

    The company announced an upgrade of the chatbot last week and claimed one of its biggest strengths was in health. It said ChatGPT – now powered by the GPT-5 model – would be better at answering health-related questions and would also be more proactive at “flagging potential concerns”, such as serious physical or mental illness. However, it stressed that the chatbot was not a replacement for professional help.

    The journal’s article, which was published last week before the launch of GPT-5, said the patient appeared to have used an earlier version of ChatGPT.

    While acknowledging that AI could be a bridge between scientists and the public, the article said the technology also carried the risk of promoting “decontextualised information” and that it was highly unlikely a medical professional would have suggested sodium bromide when a patient asked for a replacement for table salt.

    As a result, the authors said, doctors would need to consider the use of AI when checking where patients obtained their information.

    The authors said the bromism patient presented himself at a hospital and claimed his neighbour might be poisoning him. He also said he had multiple dietary restrictions. Despite being thirsty, he was noted as being paranoid about the water he was offered.

    He tried to escape the hospital within 24 hours of being admitted and, after being sectioned, was treated for psychosis. Once the patient stabilised, he reported having several other symptoms that indicated bromism, such as facial acne, excessive thirst and insomnia.

    Continue Reading

  • Emergency Colectomy for Obstruction in Microsatellite Instability Colonic Cancer: A Complete Response Following Neoadjuvant Immunotherapy

    Emergency Colectomy for Obstruction in Microsatellite Instability Colonic Cancer: A Complete Response Following Neoadjuvant Immunotherapy


    Continue Reading

  • Commonly used medications pose increased risk of memory problems, study finds

    Commonly used medications pose increased risk of memory problems, study finds



    Commonly used medications pose increased risk of memory problems, study finds 

    A new study conducted by the University of California, San Diego, unveiled that commonly prescribed anticholinergic drugs may increase the risks of mild cognitive impairment (MCI).

    Cognitive impairment is an umbrella term used to describe the decline in an individual’s ability to think, learn, remember, reason and solve problems. 

    MCI is a specific type of cognitive impairment characterized by a noticeable decline in a person’s thinking abilities. It is potentially considered as an early sign of dementia.

    The study analyzed 688 older adults of an average age of 74 years no initial cognitive issues.

    It was observed that those who took anticholinergic medications were 47% more likely to develop memory problems over a decade.

    These medicines are prescribed for conditions such as high blood pressure, allergies, and depression.

    The major findings of the study are:

    • The participants with brain markers associated with Alzheimer’s were four times more vulnerable to cognitive decline after taking these drugs.
    • Those having a genetic vulnerability to Alzheimer’s had 2.5 times higher odds of impairment.
    • Medicines like blood pressure drugs (metoprolol, atenolol), allergy medications (loratadine), and antidepressants (bupropion) highly contribute to developing cognitive impairment.

    These drugs typically inhibit the release of acetylcholine, a neurotransmitter critical for memory and learning.

    While they are effective for their intended uses, long-term usage raises cognitive concerns.

    To combat this, the study recommends exercising regularly, eating antioxidant-rich diets, and consuming certain fruits that may help to slow cognitive decline.

    The study adds to growing evidence that some medications while being advantageous for one condition may inadvertently impact brain health highlighting the need for personalized medical care. 

    Continue Reading

  • Buoyed By MAHA, Anti-Sunscreen Fad Emerges — To Dermatologists’ Dismay

    Social media influencers skeptical of sunscreen ingredients are advocating for natural alternatives, but health experts maintain sunscreen is one of the most effective tools for preventing skin cancer. “Ultraviolet radiation is a known carcinogen,” said Adam Friedman, a professor of dermatology.

    The Washington Post:
    Anti-Sunscreen Movement Sparks Concern Among Dermatologists 

    A growing anti-sunscreen movement on social media is causing concern among dermatologists, who warn that avoiding sunscreen increases long-term health risks. (Malhi, 8/10)

    The Hill:
    Dollar Store Shopping Doesn’t Equal Unhealthy Diets: Study

    Relying on dollar stores for the bulk of grocery purchases might not be harming American diets, despite the comparative lack of healthy products, a new study has found. As families look to free up funds on costly shopping lists, they are increasingly turning to their locals dollar stores to buy staple food items, according to the study, published Monday in the Journal of the Academy of Nutrition and Dietetics. (Udasin, 8/11)

    Newsweek:
    Early Warning Sign For Children’s ADHD Risk Discovered

    A developmental sign in early childhood could help to flag the future likelihood of ADHD—and ensure the right support is given at the right time. Brain wiring at this stage of life could lay the foundation for attention-related skills and hold the key to identifying young children who might go on to develop the neurodevelopmental condition. (Millington, 8/11)

    CNN:
    Fast Walking Is A Key To Longevity, Research Shows 

    Too busy to go to the gym? Don’t worry — you can stay healthy by incorporating at least 15 minutes of fast walking into your everyday routine, new research suggests. (Park, 8/11)

    Stat:
    More Men Than Ever Are Getting Plastic Surgery. Here’s Why 

    Even after Chris Sanford lost 130 pounds, he struggled with body dysmorphia. Every time he looked at the streamlined bodies on his social media feed, he was reminded about the folds of excess skin drooping from his own torso. It made him feel far larger than he really was. (Goldhill, 8/12)

    In celebrity news —

    AP:
    Tennis Great Monica Seles Says She Has Myasthenia Gravis. It Is A Chronic Neuromuscular Disease

    Monica Seles first noticed the symptoms of myasthenia gravis — a neuromuscular autoimmune disease she discussed during a recent interview with The Associated Press — while she was swinging a racket the way she’d done so many times during, and after, a career that included nine Grand Slam titles and a place in the International Tennis Hall of Fame. (Fendrich, 8/12)


    This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.

    Continue Reading

  • Remission of Abdominal Migraines Following Chiropractic Care for Thoracic Scoliosis

    Remission of Abdominal Migraines Following Chiropractic Care for Thoracic Scoliosis


    Continue Reading

  • Global burden of early-onset cardiovascular disease attributable to fine particulate matter pollution from 1990 to 2021: a systematic analysis for the global burden of disease study 2021 | BMC Medicine

    Global burden of early-onset cardiovascular disease attributable to fine particulate matter pollution from 1990 to 2021: a systematic analysis for the global burden of disease study 2021 | BMC Medicine

    This study provides an up-to-date evaluation on the global, regional, and national burden of early-onset CVD attributable to PM2.5 from 1990 to 2021. Males, individuals living in regions with lower SDI, and those with IHD experience a higher burden. Over the past three decades, there was a substantial decrease in early-onset CVD burden attributable to total and household PM2.5, especially in regions with higher SDI. However, the corresponding burden from ambient PM2.5 continued to rise and only began to decline since the last decade. In addition, the reduction in early-onset CVD burden was less prominent than that of late-onset CVD. Such findings underscore that even in the context of global population aging, the PM2.5-related early-onset CVD burden remains a critical concern.

    Most previous studies focused on the overall CVD burden attributable to PM2.5, with few age-specific analyses and insufficient attention to younger populations [13, 15, 21]. Besides, there has been a decreasing trend in the all-age CVD death and DALY rates attributable to both ambient and household PM2.5 exposure over the past three decades [9]. However, how the early-onset CVD burden varied across different regions and time periods remains unclear. Our study is the first to fill this gap by conducting a comprehensive analysis of early-onset CVD burden attributable to PM2.5 from 1990 to 2021 at the global level. We also present the late-onset CVD burden and age-specific burden by 5-year intervals. The results show that the attributable burden was consistently higher in older age groups, suggesting their greater susceptibility. Interestingly, while the burden of both early- and late-onset CVD from total and household PM2.5 has declined, the reduction in the early-onset burden is smaller compared to the late-onset burden. Additionally, in contrast to the decline in late-onset CVD burden, the early-onset CVD burden due to ambient PM2.5 even increased slightly. This suggests a need for sustained attention to younger populations who may experience slower improvements despite lower absolute burden.

    Our study reveals obvious sexual differences in the burden of early-onset CVD attributable to PM2.5 pollution. In general, males experience a higher burden compared to females, which is consistent with higher PM2.5-related CVD risk among males reported in previous researches [22,23,24]. This between-sex difference is more pronounced for ambient PM2.5 pollution and less prominent for household PM2.5. Several factors might contribute to this heterogeneity. First, there is generally a higher prevalence of traditional cardiovascular risk factors among males, such as hypertension, alcohol consumption, and smoking, which contributed to a higher overall CVD burden [9, 25, 26]. Second, social and occupational factors might also play an important role. Men are more likely to engage in outdoor labor-intensive work, leading to greater exposure to ambient air pollution. Conversely, women are more often exposed to indoor air pollution due to their involvement in household tasks such as cooking [27, 28]. These results underscore the importance of accounting for sex-specific exposure patterns when designing public health policies aimed at reducing PM2.5-related disease burdens. Reducing ambient PM2.5 exposure is particularly important for mitigating CVD burden among men, while minimizing both ambient and indoor exposure would be equally crucial for women.

    Substantial variations by SDI were illustrated in the burden of early-onset CVD attributable to PM2.5 pollution. Similar to patterns observed in studies on other non-communicable diseases [29], a reversed U-shaped association was found between SDI and the early-onset CVD burden attributable to ambient PM2.5. In contrast, the corresponding burden due to household PM2.5 showed a generally decreasing trend as SDI increased. Low-SDI regions in Sub-Saharan Africa and South Asia faced the highest burden from household PM2.5, while middle-SDI regions in North Africa, the Middle East, South Asia, and East Asia experienced the greatest burden from ambient PM2.5. This pattern could be explained by the regional economic and environmental differences. Specifically, low-SDI countries, largely dependent on solid fuels, have higher household PM2.5 exposure, whereas middle-SDI countries face increased ambient pollution due to rapid urbanization and industrialization [30, 31]. High-SDI regions had the lowest burden from both ambient and household PM2.5, which might be largely due to the use of cleaner energy, stricter environmental regulations, more resources of individual protective measures, and improved public health and clinical systems. These regional differences underscore the critical influence of socioeconomic development on the early-onset CVD burden attributable to PM2.5 pollution.

    To effectively mitigate the early-onset CVD burden due to PM2.5 pollution, tailored air quality policies and interventions based on regional economic and environmental contexts are warranted. In low-SDI countries, international cooperation is essential, including technology transfer to promote clean cooking stoves, clean energy use, and improved household ventilation. Global financial support is also needed to subsidize infrastructure upgrades and clean energy transitions. For middle-SDI countries undergoing rapid industrialization and urbanization, stringent air quality management plans including tightening industrial emission standards, expanding public transportation systems, and promoting clean energy transitions are needed. High-SDI countries, while facing relatively lower PM2.5 burdens, should continue strengthening environmental regulations, advancing control technologies, and investing in long-term pollutant management. They can also play a leading role in supporting global air pollution control efforts through research collaboration, funding, and cross-border policy communication.

    The health effects and corresponding disease burden attributable to PM2.5 may also vary depending on its chemical composition and sources, which differ substantially across regions [32]. Previous studies reported that carbonaceous components and PM2.5 from fossil fuel combustion might pose higher cardiovascular risks [33,34,35,36], which could theoretically contribute to a higher disease burden. However, due to data limitations, our analysis focused on total PM2.5 mass and did not account for the heterogeneity in chemical constituents and sources. This limitation may also contribute to uncertainties in regional burden estimates. Future studies integrating data on PM2.5 chemical composition and source-specific toxicity are warranted to improve the precision of disease burden estimates and guide more targeted interventions.

    Over the past three decades, there has been a significant decrease in the early-onset CVD burden attributable to total and household PM2.5 pollution, especially in regions with higher SDI levels. In contrast, the burden from ambient PM2.5 slightly increased at the global level, which was mainly driven by increasing burden in less-developed regions [31]. Since the year 2012, early-onset CVD burden from ambient PM2.5 has exceeded that from household PM2.5, and became the primary contributor to PM2.5-related burden. This shift illustrates the effectiveness of the global efforts in promoting cleaner energy sources including natural gas and electricity for household use, and emphasizes that stricter actions especially on ambient PM2.5 pollution are needed to reduce CVD burden in the future.

    This study provides a comprehensive and up-to-date evaluation on the global, regional, and national distributions and temporal trends of early-onset CVD burden from PM2.5 exposure. Our findings offer scientific guidance for multiple fields, including public health, clinical practice, and environmental health policy, in developing targeted interventions and management strategies to promote global cardiovascular health.

    There are several limitations that should be acknowledged. First, PM2.5 is a complex mixture comprising multiple constituents, each with distinct physicochemical properties [37]. The composition of PM2.5 can vary significantly by source, season, and region [38, 39]. However, the GBD 2021 study assumes spatial homogeneity in PM2.5 composition, potentially leading to inaccurate estimations in specific locations [29]. Future studies should take the heterogeneity of PM2.5 composition and source into consideration when evaluating the disease burden attributable to PM2.5. Second, our assessment of household PM2.5 pollution did not account for solid fuel use for heating, which is also an important contributor to indoor air pollution and a known risk factor for CVD [9, 40]. Thus, future studies should explore the contribution of solid fuel use for heating to the disease burden attributable to household PM2.5 pollution. Third, the effect estimates in this study rely on available epidemiological datasets, which might be limited in many low- and middle-income regions. Issues such as underdiagnosis and inadequate health care access could lead to biases in the estimation. Fourth, the current GBD 2021 dataset only evaluates burden of IHD as an aggregated category. Therefore, we were unable to estimate the disease burden by finer subtypes of IHD such as acute myocardial infarction, angina, or chronic IHD separately. In addition, most existing cohort studies on air pollution have focused on overall IHD rather than its specific subtypes, leading to insufficient evidence supporting more detailed burden estimation. Therefore, future studies with finer disease categories are warranted and would be valuable to inform targeted interventions. Last, while the relative risk estimates used in GBD 2021 were derived from epidemiological studies that adjusted for major confounders, residual confounding from unmeasured factors may still exist. In addition, potential interactions and mediation among different risk factors are not fully captured in these models. Future studies incorporating more detailed covariate data and advanced analytical methods are needed to better account for residual confounding and to explore these complex relationships.

    Continue Reading

  • A Case of Oral Lichen Planus Unresponsive to Dental Metals Removal Des

    A Case of Oral Lichen Planus Unresponsive to Dental Metals Removal Des

    Introduction

    Metal allergies can cause inflammatory conditions affecting the skin and mucous membranes, often complicating diagnoses when associated with dental prostheses. Differentiating between allergic reactions to dental metals and other inflammatory lesions, such as oral lichen planus, can be difficult in the oral cavity. Oral lichen planus is a chronic inflammatory condition with multiple possible etiologies, including autoimmune responses, infections, medications, and, in some cases, metal allergies.

    Previous studies have reported an association between dental metal restorations and oral lichen planus, leading to the recommendation of metal removal as a treatment option.1 However, the persistence of symptoms following metal removal suggests that other pathologies, such as oral lichen planus, may play a more significant role.2 This case report presents a patient with persistent oral lesions initially attributed to metal allergies, where treatment targeting the suspected allergy was unsuccessful, ultimately revealing oral lichen planus as the primary diagnosis.

    Patients and Methods

    Patient Information

    A 55-year-old female patient presented with redness and pain in the buccal gingiva near the right mandibular first molar (#46). Her medical history included atrophic gastritis, and she had a known metal allergy. The patient had no previous history of oral lichen planus. The patient’s family history was unremarkable.

    Present Illness

    The patient was referred to our department from a dermatology clinic specializing in allergies and presented with symptoms suggestive of a metal allergy, including redness and lace-like white patches on the buccal gingiva adjacent to tooth #46. Redness and lace-like white patches were observed on the buccal gingiva near tooth #46, accompanied by pain and inflammation (Figure 1).

    Figure 1 Redness and lace-like white patches on the buccal gingiva near tooth #46, with associated pain and inflammation.

    Clinical Findings

    Upon intraoral examination, full-cast crowns were identified on teeth #16, #17, #26, #27, #36, #37, #46, and #47, whereas partial-cast crowns were found on teeth #24, #25, #34, and #35 using the FDI two-digit tooth numbering system.3 Tooth #45 was restored with a composite resin, and the remaining teeth were natural (Figure 2). No extra-oral abnormalities were observed.

    Figure 2 Full cast crowns on teeth #16, #17, #26, #27, #36, #37, #46, and #47, and partial cast crowns on teeth #24, #25, #34, and #35. Composite resin restoration on tooth #45.

    Intraoral Metal Element Analysis

    Samples were collected from all intraoral restorations using a silicone point (M3-28, Shofu, Kyoto) and analyzed using an X-ray fluorescence spectrometer (MESA-500W, HORIBA, Kyoto). The analysis detected the presence of Zn and Co in full-cast crowns on teeth #16, #17, #26, #27, #36, #37, #46, and #47, as well as in partially-cast crowns on teeth #24, #25, and #34 (Table 1).

    Table 1 Intraoral Metal Element Analysis of Dental Crowns

    Diagnosis and Treatment

    Based on the intraoral metal element analysis, a diagnosis of metal allergy was confirmed.4 In September 2021, the metal crowns were removed and replaced with provisional restorations made of autopolymerizing resin. During the crown removal, suction, gauze, and an extraoral vacuum were employed to prevent exposure to metal fragments. No acute symptoms were observed postoperatively. Full-zirconia ceramic crowns were placed in December 2021. However, redness and pain persisted even eight months after crown placement (Figure 3).

    Figure 3 Persistent redness and pain in the buccal mucosa eight months after zirconia crowns were placed on teeth #46.

    Subsequently, in August 2022, the metal crown of the right mandibular second molar (#47) was removed and replaced with a full zirconia ceramic crown, similar to the approach used for tooth #46 (Figure 4). Despite these interventions, the symptoms did not subside, prompting reconsideration of the initial diagnosis. The patient was referred to the Department of Oral and Maxillofacial Surgery.

    Figure 4 White patches remained on the oral mucosa after the healing of oral lichen planus.

    Further Diagnostic Evaluation and Outcome

    In November 2022, a punch biopsy was performed, which confirmed a diagnosis of oral lichen planus through histopathological analysis. Subsequently, the oral surgeon initiated steroid therapy, including dexamethasone 0.1% oral ointment and azunol 4% mouthwash. Regular follow-up (monthly) showed gradual resolution of the mucosal inflammation, and by March 2023, the oral lichen planus had fully healed (Figure 5). The patient was continuously monitored for recurrence.

    Figure 5 Oral cavity overview after the healing of oral lichen planus.

    Results

    This case represents an unusual presentation of oral lichen planus that was initially diagnosed as a metal allergy-induced lesion. The removal of dental metals and their replacement with zirconia crowns did not lead to symptom improvement, suggesting that metal allergy was not the sole cause of the patient’s symptoms. Successful resolution following steroid therapy supports the hypothesis that oral lichen planus rather than metal allergy is the primary pathology.

    Discussion

    Dental metal allergies can manifest in various ways, and management approaches should take into account factors such as mucocutaneous symptoms, the involvement of allergy-positive metals, and individual patient response to the removal of dental metals.5 In this case, despite the detection of allergy-positive metals (Zn and Co), mucosal inflammation persisted following metal removal. This finding underscores the need for a comprehensive approach to diagnosing oral lesions, particularly in patients with complex presentations.6 Differential diagnoses considered included lichenoid contact reaction, systemic lupus erythematosus, and mucous membrane pemphigoid. These were ruled out based on clinical presentation and histopathological features. Oral lichen planus has been linked to various etiologies beyond metal allergies, including bacterial and viral infections, medications, stress, and autoimmune diseases.7 In cases where metal allergy is suspected, but symptoms persist despite the allergen removal, other potential causes, such as oral lichen planus, must be carefully evaluated. In this case, the efficacy of steroid therapy highlights the importance of considering alternative treatments, including immunosuppressants, antiviral medications, and biologics, especially in patients who do not respond to conventional therapies.8

    Chronic oral lichen planus can severely impact a patient’s quality of life due to persistent pain and discomfort.9 Therefore, treatment goals should not only focus on symptom relief and recurrence prevention but also on improving the patient’s overall quality of life. Patient education and regular follow-ups are essential components of long-term management.10

    Conclusion

    This case highlights the need for a multidisciplinary approach to manage oral inflammatory conditions. Prosthodontists and dental practitioners should consider various perspectives and collaborate with other departments when facing persistent oral lesions, particularly when treatments targeting suspected metal allergies fail to yield positive results and desired outcomes. Alternative diagnoses, such as oral lichen planus, should be considered, and appropriate interventions should be implemented to achieve optimal patient care.

    Acknowledgments

    We would like to express our gratitude to Dr. Kitagawa from the Center of Oral Clinical Examination and Dr. Taguchi from the Department of Oral and Maxillofacial Surgery for their dedicated efforts in managing this condition.

    Additionally, the patient provided written informed consent for the publication of this case report, including the use of clinical images. Ethical approval was not required for this case report, as no identifiable personal information is disclosed, and institutional guidelines at Hiroshima University Hospital do not require IRB review for single case reports.

    Author Contributions

    All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

    Disclosure

    The authors report no conflicts of interest in this work.

    References

    1. Sugiyama M, Kawashima A, Ishida K, et al. Clinical features of oral lichen planus related to dental metal restorations. Oral Sci Int. 2012;9(2):81–85.

    2. Kato T, Matsuda S, Ishikawa J, et al. Refractory oral lichen planus after dental metal replacement: a retrospective study. J Dermatol. 2020;47(5):506–512.

    3. FDI World Dental Federation. FDI two-digit tooth numbering system. Int Dent J. 1971;21(1):104–106.

    4. Sakanashi EN, Kikuchi K, Matsumura M, et al. Chapter 7-Allergic contact dermatitis to dental alloys: evaluation, diagnosis and treatment in Japan — reflectance confocal laser microscopy, an emerging method to evaluate allergic contact dermatitis. In: Confocal Laser Microscopy – Principles and Applications in Medicine, Biology, and the Food Sciences. 2013.

    5. Akiba Y, Watanabe M, Mine A, et al. With the aim of treatment guideline development for dental metal allergy and related diseases. Ann Jpn Prosthodont Soc. 2016;8(4):327–339. doi:10.2186/ajps.8.327

    6. Stone SJ, McCracken GI, Heasman PA, et al. Cost-effectiveness of personalized plaque control for managing the gingival manifestations of oral lichen planus: a randomized controlled study. J Clin Periodontol. 2013;40:859–867. doi:10.1111/jcpe.12126

    7. Louisy A, Humbert E, Samimi M. Oral lichen planus: an update on diagnosis and management. Am J Clin Dermatol. 2024;25:35–53. doi:10.1007/s40257-023-00814-3

    8. Rotaru D, Chisnoiu R, Picos AM, et al. Treatment trends in oral lichen planus and oral lichenoid lesions (Review). Exp Ther Med. 2020;20:198. doi:10.3892/etm.2020.9328

    9. Salgado DS, Jeremias F, Capela MV, et al. Plaque control improves the painful symptoms of oral lichen planus gingival lesions. A short-term study. J Oral Pathol Med. 2013;42:728–732. doi:10.1111/jop.12093

    10. Hashemipour MA, Sheikhhoseini S, Afshari Z, et al. The relationship between clinical symptoms of oral lichen planus and quality of life related to oral health. BMC Oral Health. 2024;24:556. doi:10.1186/s12903-024-04326-2

    Continue Reading

  • Advances in Data-Driven Early Warning Systems for Sepsis Recognition and Intervention in Emergency Care: A Systematic Review of Diagnostic Performance and Clinical Outcomes

    Advances in Data-Driven Early Warning Systems for Sepsis Recognition and Intervention in Emergency Care: A Systematic Review of Diagnostic Performance and Clinical Outcomes


    Continue Reading